- Home
- XTNT vs SEER Comparison
XTNT vs SEER Comparison
Compare XTNT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- SEER
- Stock Information
- Founded
- XTNT N/A
- SEER 2017
- Country
- XTNT United States
- SEER United States
- Employees
- XTNT N/A
- SEER N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- SEER Medicinal Chemicals and Botanical Products
- Sector
- XTNT Health Care
- SEER Health Care
- Exchange
- XTNT Nasdaq
- SEER Nasdaq
- Market Cap
- XTNT 110.6M
- SEER 113.8M
- IPO Year
- XTNT N/A
- SEER 2020
- Fundamental
- Price
- XTNT $0.76
- SEER $2.09
- Analyst Decision
- XTNT
- SEER
- Analyst Count
- XTNT 0
- SEER 0
- Target Price
- XTNT N/A
- SEER N/A
- AVG Volume (30 Days)
- XTNT 389.4K
- SEER 95.9K
- Earning Date
- XTNT 11-11-2025
- SEER 11-06-2025
- Dividend Yield
- XTNT N/A
- SEER N/A
- EPS Growth
- XTNT N/A
- SEER N/A
- EPS
- XTNT N/A
- SEER N/A
- Revenue
- XTNT $127,766,000.00
- SEER $16,376,999.00
- Revenue This Year
- XTNT $13.03
- SEER $25.97
- Revenue Next Year
- XTNT N/A
- SEER $24.00
- P/E Ratio
- XTNT N/A
- SEER N/A
- Revenue Growth
- XTNT 15.16
- SEER 12.11
- 52 Week Low
- XTNT $0.33
- SEER $1.62
- 52 Week High
- XTNT $0.95
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- XTNT 48.70
- SEER 40.03
- Support Level
- XTNT $0.73
- SEER $2.12
- Resistance Level
- XTNT $0.95
- SEER $2.29
- Average True Range (ATR)
- XTNT 0.07
- SEER 0.10
- MACD
- XTNT -0.01
- SEER -0.02
- Stochastic Oscillator
- XTNT 14.00
- SEER 12.33
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.